期刊文献+

食管癌及癌前病变食管粘膜中端粒酶活性的检测及临床意义

Detection of Telomerase Activity in Esophageal Carcinoma Tissue and Precancerous Lesions
下载PDF
导出
摘要 目的 :探讨食管癌及癌前病变食管粘膜中端粒酶的表达及临床意义。方法 :采用端粒末端重复序列扩增技术(TRAP)检测 4 4例食管癌组织 ,31例不典型增生 ,15例正常食管粘膜组织中端粒酶活性。结果 :4 4例食管癌组织中 ,35例端粒酶呈阳性表达 ,阳性率为 79.5 4 %。 31例不典型增生组织中 ,18例端粒酶呈阳性表达 ,阳性率为 5 8.1%。 15例正常食管粘膜组织中 ,仅有 4例端粒酶呈阳性表达 ,阳性率为 2 6 .6 7%。统计学分析 ,3组比较端粒酶阳性表达有显著性差异 (P <0 .0 5 )。食管癌组织中端粒酶表达与浸润深度、大体类型、组织分化程度及淋巴结转移均无关。结论 :端粒酶的激活在食管癌的发生发展中起着重要作用 ,检测端粒酶活性对预测食管癌的发生和早期诊断有重要价值。 Objective: To detect the telomerase activity in human esophageal carcinoma and precancerous leisions tissues, further more, to explor the relationship between telomerase activity and clinical pathologic factors of the esophageal carcinoma. Methods: Telomerase activity in specimens from 44 patients with esophageal carcinoma, 31patients with dysplasis tissue and 15patents of normal esophageal tissue were measured by TRAP. Results: It was found that telomerase activity was positive in 35 of 44 esophageal tissues (79.54%), in 18 of 31 dysplasis tissue specimens (58.10%) and in 4 of 15 normal esophageal tissues (26.67%). There were statistically significant difference between esophageal carcinoma, dysplasis tissue and normal esophageal tissue. No significant correlation was found between telomerase activity and the depth of infiltration or differentiated grade of tumor and lymph nodes metastasis. Conclusion: The presence of telomerase activity may play an important role in esophageal carcinogenesis. Telomerase activity might be a good marker in estimating the occurrence and progression of esophageal carcinoma.
出处 《江苏大学学报(医学版)》 CAS 2003年第4期317-319,共3页 Journal of Jiangsu University:Medicine Edition
  • 相关文献

参考文献10

  • 1朱芮,熊永炎,林宜先.端粒、端粒酶与胃癌[J].肿瘤防治研究,2001,28(2):148-150. 被引量:2
  • 2Hoos A, Hepp HH, Kaul S, et al. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer[J]. Int J Cancer, 1998,79:8.
  • 3Kim NW, Piatyszek MA, Prowse KR, et al. Specific Association of human telomerase activity with immortal cells and cancer[J]. Science, 1994,266:2011 - 2015.
  • 4Takubo K, Nakamura K, Izumiyama N, et al. Telomerase activity in esophageal carcinoma[J]. J Surg Oncol,1997,66(2) :88 - 92.
  • 5Hiyama K, Hiyama E, Ishiok S, et al. Telomerase activity in small-cell and non-small cell lung cancer[J]. J Natl Cancer Inst. 1995,87:895 - 902.
  • 6Yashima K, Milchgrub S, Gollahon LS, et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma[J]. Clin Cancer Res, 1998, 4:229-234.
  • 7Tsao JL, Zhao Y, Lukas J, et al, Telomerase activity in normal and neplastic breast[J]. Clin Cancer Res, 1997,3:627 - 631.
  • 8Umbricht CB, Saji M, Westra WH, et al. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma[J]. Cancer Res, 1997, 57 (11) :2144 - 2148.
  • 9Nakatani K, Yoshimi N. The significant role of telomerase activity in human brain tumors[J]. Cancer, 1997,80(3) :471-474.
  • 10Scates DK, Muir GH, Venirt S, et al. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer[]]. Br J Urol, 1997, 80(2) :236 -266.

二级参考文献6

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部